Article Fingerprint
ReserarchID
U6XGP
Crossref Journal DOI 10.17406/GJSFR
Print ISSN 0975-5896
e-ISSN 2249-4626
Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.
Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.
This paper attempted to assess the attitudes of students in
Advances in technology have created the potential for a new
Inclusion has become a priority on the global educational agenda,
Juvenile idiopathic arthritis (JIA) is a heterogeneous pathology with uncertain causative factors and prognosis, stemming from an immune system dysfunction with the development of autoimmune reactions. The most distinctive and potentially most severe of these is systemic JIA (sJIA), a disease characterized by sharp rises in temperature and rash. A thorough understanding of the complex of immune regulatory mechanisms along with genetic analysis reveals complex relationships between autoimmune reactions and auto inflammation. Sequencing of 15 auto inflammatory genes was performed in 62 patients with JIA: 26 -oligoarthritis, 20 -polyarthritis, 16 -systemic. Studies have shown that 16 (25.8%) patients with the clinical JIA phenotype had changes in nucleotide sequence in the genes encoding auto inflammatory immune response proteins. NOD2 changes were in 12 (19.3%) of them and 1 change in each of the 4 patients NLRP12 (heterozygote, c.1343G> C (p.Gly448Ala)), MEFV (pathogenic heterozygous, c.2082G> A (p.Met694Ile)), ADA2 (heterozygote, c.145C> T). Arg49Trp)), PSTPIP1 (heterozygote, c.806T> A (p.Ile269A)) in the group of studied children with JIA. The study will allow identifying individual genetic loci of JIA risk, expand understanding of the pathogenesis and spectrum of phenotypic manifestations of the disease, improve diagnosis and prediction of its course, as well as reveal new opportunities for monitoring patients with JIA and their personalized therapy.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
